Commentary|Articles|May 13, 2026

How ctDNA and Liquid Biopsies Could Transform Breast Cancer Care

ctDNA liquid biopsies detect breast cancer at molecular levels to guide personalized therapy and monitor for recurrence or progression.

For many patients diagnosed with early-stage breast cancer, the clinical road map feels relatively predictable: surgery, perhaps radiation or chemotherapy and the hope for a cure. But for Amy Ferris, a consulting and information technology (IT) professional in Austin, Texas, that standard map was missing a critical detour.

Related to this article

October 15th, 2026

3 Weeks of Breast Radiation Had Similar Reconstruction Complications as 5 Weeks

In the phase 3 RT CHARM trial, published Oct. 12, 2026, in the Journal of Clinical Oncology, a three-week course of radiation after mastectomy caused about the same rate of reconstruction complications as the standard five-week course in women with breast cancer.

October 14th, 2026

FDA Flags Possible Colitis Risk With CDK4/6 Breast Cancer Drugs

The FDA flagged potential safety signals for colitis with Ibrance, Kisqali and Verzenio, and heart inflammation with melanoma drugs. No causal link is confirmed.

October 12th, 2026

Who Should Get Genetic Testing After a Cancer Diagnosis?

A study of 39,184 people with solid tumors, published Oct. 8, 2026, found that about 1 in 6 had an inherited genetic change that increased their cancer risk. Testing only people under 50 would have missed 72% of those with these changes.

October 16th, 2026

Medical Debt Linked to More Late-Stage Lung and Other Cancers

U.S. counties where more residents had medical debt in collections had higher rates of late-stage lung, head and neck, colorectal and several other cancers, according to a study of 2,958 counties published in October 2026 in JAMA Network Open.

October 16th, 2026

Stage 4 Breast Cancer: How a Second Opinion Saved Her Life

Diagnosed with stage 4 breast cancer weeks after giving birth, Eileen Carter explains why getting a second opinion changed the course of her care.

October 16th, 2026

Libtayo, Osteosarcoma and More: 5 Other ESMO 2026 Abstracts to Watch

Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch.

October 15th, 2026

Dense Breasts on Your Mammogram Report? What It Means for You

Since September 2024, every U.S. mammogram report must tell patients whether their breast tissue is dense. Here is what that notice means, why it matters and what to ask your care team.

October 15th, 2026

Diagnosed With Stage 4 Breast Cancer Weeks After Giving Birth

Diagnosed with stage 4 breast cancer weeks after giving birth, Eileen Carter and her chaplain husband share why a second opinion changed everything.